Cutaneous infection with rapidly growing mycobacteria in patients with systemic rheumatic disease.
We report two patients with systemic rheumatic disease being treated with steroids whose cases were complicated by subcutaneous nodules. In both, clinical and histological features suggested cutaneous infection and M. chelonae was isolated from skin specimens. Antibiotic therapy in both and surgery in one led to healing after a prolonged course. A review of the literature and our experience with these two patients suggest that rheumatic patients on steroid therapy are at risk of infection with these unusual pathogens. Knowledge of the risk factors and the distinctive picture of cutaneous mycobacteriosis should improve its diagnosis and therapy.
Pablos
J L
JL
Department of Rheumatology, Hospital Doce de Octubre, Madrid, Spain.
Poveda
M J
MJ
Ciruelo
E
E
Palenque
E
E
Alonso
J
J
Mateo
I
I
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications*; D003646:Debridement; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D014382:Tuberculosis, Cutaneous / Q000150:complications* / Q000188:drug therapy / Q000601:surgery
D000900:Anti-Bacterial Agents